Cargando…
Association Between Contrast-Enhanced Ultrasound Indicators and Prostate Cancer Biochemical Recurrence After Treatment
BACKGROUND: Some patients with prostate cancer (PCa) will experience biochemical recurrence (BCR) after treatment. Current researches have identified the influencing factors of BCR, but these factors are difficult to quantify and hence unable to accurately predict the BCR in PCa patients. OBJECTIVE:...
Autores principales: | Mei, Jiang-jun, Zhao, Yun-xin, Jiang, Yi, Wang, Jian, Yu, Jia-shun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326692/ https://www.ncbi.nlm.nih.gov/pubmed/32636672 http://dx.doi.org/10.2147/CMAR.S250907 |
Ejemplares similares
-
Contrast-enhanced transrectal ultrasound can reduce collection of unnecessary biopsies when diagnosing prostate cancer and is predictive of biochemical recurrence following a radical prostatectomy in patients with localized prostate cancer
por: Zhao, Hong-wei, et al.
Publicado: (2020) -
Nomogram Incorporating Contrast-Enhanced Ultrasonography Predicting Time to the Development of Castration-Resistant Prostate Cancer
por: Zhao, Yun-xin, et al.
Publicado: (2021) -
Contrast-Enhanced Ultrasound-Magnetic Resonance Imaging Radiomics Based Model for Predicting the Biochemical Recurrence of Prostate Cancer: A Feasibility Study
por: Wang, Yong, et al.
Publicado: (2022) -
Contrast-Enhanced Ultrasound to Monitor Early Recurrence of Primary Hepatocellular Carcinoma after Curative Treatment
por: Liu, Lian-Feng, et al.
Publicado: (2018) -
Novel model combining contrast-enhanced ultrasound with serology predicts hepatocellular carcinoma recurrence after hepatectomy
por: Tu, Hai-Bin, et al.
Publicado: (2021)